Forebrain Lineage Factor DMRTA2 Is Not Required for Maintenance of H3G34 ‐Mutant Paediatric High‐Grade Gliomas
Journal of Cellular and Molecular Medicine · 2026-07 · 30 (14)
DOI: 10.1111/jcmm.71302 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 25.07.2026. Verfasst von Raul B Bressan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Spanish National Cancer Research Centre, Madrid, Spain. Hauptthemen laut MEDLINE: Glioma, Mutation, Brain Neoplasms, Histones. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agencia Estatal de Investigación, Ministerio de Ciencia, Innovación y Universidades, Fundación Científica Asociación Española Contra el Cáncer.
Abstract (Originalsprache)
Developmental transcriptional programs are increasingly recognized as key drivers of paediatric gliomagenesis. Here, we unexpectedly find that the forebrain‐specific doublesex‐ and mab‐3‐related transcription factor a2 (DMRTA2), despite being highly expressed in H3G34‐mutant diffuse hemispheric glioma (DHG‐H3G34) and implicated in tumour initiation, is not required for the maintenance of established patient‐derived tumour cells. These findings support a stage‐specific framework in which transcriptional dependencies are dynamically rewired during tumour progression in paediatric brain tumours.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Spanish National Cancer Research Centre, Madrid, Spain.
- Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts, USA.
- Division of Hematopoietic Innovative Therapies, Biomedical Innovation Unit, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, Madrid, Spain.
- Advanced Therapies Unit, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Madrid, Spain.
- Centro de Investigación Biomédica en Red de Enfermedades Raras, Madrid, Spain.
- Centre for Regenerative Medicine, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK.
ORCID-Profile: Raul B Bressan, Oliva Sanchez, Carlos Alberto Oliveira de Biagi-Junior, Raúl Torres-Ruiz, Gustavo Alencastro Veiga Cruzeiro, Irene Salgado, Sandra Rodriguez-Perales, Eduardo Caleiras, Manuel Valiente
Förderung
- Agencia Estatal de Investigación
- Ministerio de Ciencia, Innovación y Universidades
- Fundación Científica Asociación Española Contra el Cáncer
- Fundacion la Caixa
- Instituto de Salud Carlos III
Zitieren
APA
Bressan, R. B., Sanchez, O., Biagi-Junior, C. A. O., Torres-Ruiz, R., Cruzeiro, G. A. V., Salgado, I., Rodriguez-Perales, S., Caleiras, E., Vega, Z., Morrison, G., Pollard, S. M., Filbin, M. G., & Valiente, M. (2026). Forebrain Lineage Factor DMRTA2 Is Not Required for Maintenance of H3G34 ‐Mutant Paediatric High‐Grade Gliomas. Journal of Cellular and Molecular Medicine, 30(14). https://doi.org/10.1111/jcmm.71302
Vancouver
Bressan RB, Sanchez O, Biagi-Junior CAO, Torres-Ruiz R, Cruzeiro GAV, Salgado I, et al. Forebrain Lineage Factor DMRTA2 Is Not Required for Maintenance of H3G34 ‐Mutant Paediatric High‐Grade Gliomas. Journal of Cellular and Molecular Medicine. 2026;30(14). doi:10.1111/jcmm.71302
BibTeX
@article{Bressan2026,
author = {Bressan, Raul B and Sanchez, Oliva and Biagi-Junior, Carlos Alberto Oliveira de and Torres-Ruiz, Raúl and Cruzeiro, Gustavo Alencastro Veiga and Salgado, Irene and Rodriguez-Perales, Sandra and Caleiras, Eduardo and Vega, Zaira and Morrison, Gillian and Pollard, Steven M and Filbin, Mariella G and Valiente, Manuel},
title = {Forebrain Lineage Factor DMRTA2 Is Not Required for Maintenance of H3G34 ‐Mutant Paediatric High‐Grade Gliomas},
journal = {Journal of Cellular and Molecular Medicine},
year = {2026},
volume = {30},
number = {14},
doi = {10.1111/jcmm.71302}
}
EUVIMED